Share Your Research, Maximize Your Social Impacts
A case report of all-trans retinoic acid-induced pseudotumor cerebri in an adult patient of acute promyelocytic leukemia
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 5)Publication Date: 2014-10-01
Authors : Akhil Kapoor; Narender Kumar; Raj Kumar Nirban; Ashok Kalwar; Harvindra Singh Kumar;
Page : 918-920
Keywords : All-trans retinoic acid; Pseudotumor cerebri; Adult; Acute promyelocytic leukemia;
Source : Download
Find it from : Google Scholar
Abstract
All-trans retinoic acid (ATRA), a derivative of vitamin A, is the first line drug for acute promyelocytic leukemia (APL). At the same time, ATRA is also associated with various side effects, including some life threatening conditions. We describe a case of ATRA-induced pseudotumor cerebri in an adult patient of APL.
Other Latest Articles
- Possible adverse drug reaction to parenteral amino acids in an infant: a case report
- Sudden hearing loss in a patient of Hodgkin's lymphoma following vinblastine chemotherapy: a rare case report and review of the literature
- Imatinib resistance in chronic myelogenous leukemia: an emerging challenge
- The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
- Prescription audit study in a tertiary care hospital using the anatomical therapeutic chemical and defined daily dose classification concept
Last modified: 2014-10-25 16:50:48